Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

Overview of attention for article published in British Journal of Cancer, June 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet
policy: 3 policy sources

twitter: 7 X users

Citations

dimensions_citation: 159 Dimensions

Readers on

mendeley: 91 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 4 policy documents that reference this research output.

Opdivo in combo with Yervoy for Renal Cell Carcinoma – Details

Cited by Canadian Agency for Drugs and Technologies in Health on 01 Jun 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Konsultationsfassung: Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms : Langfassung der Leitlinie "Konsultationsfassung: Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms "

Cited by The Association of the Scientific Medical Societies in Germany on 20 Aug 2021

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.

Pembrolizumab with axitinib for untreated advanced renal cell carcinoma : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 05 Feb 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Cabozantinib for previously treated advanced renal cell carcinoma: Committee papers

Cited by National Institute for Health and Care Excellence on 10 Apr 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.